학술논문
445TiP VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S738-S738
Subject
Language
ISSN
0923-7534